Abstract:Objective To explore the molecular mechanism of Sacubitril/Valsartan Sodium improving heart failure cell model and animal model through Nrf2/HO-1 signaling pathway.Methods H9C2 cells were treated with Doxorubicin hydrochloride (DOX) to construct a heart failure cell model, and then treated with Sacubitril/Valsartan Sodium (LCZ696) and Nrf2 inhibitor (ML385), respectively. They were divided into five groups: Control, DOX, DOX + LCZ696, DOX + ML385, DOX + LCZ696 + ML385. Mice model of heart failure was induced by DOX and treated with LCZ696 and ML385, which were divided into sham operation group, DOX group, DOX + LCZ696 group, and DOX + LCZ696 + ML385 group. Cell viability and apoptosis was analyzed by CCK-8 and flow cytometry. ROS, MDA and SOD levels were detected with the kit. The levels of TNF-α, IL-1β and IL-6 were detected by ELISA. Bax, Bcl-2, C-caspase-3, Nrf2 and HO-1 proteins was detected via Western blotting. Heart tissue of mice with heart failure was stained by HE, Masson and TUNEL.Results Compared with control group, DOX-induced cell viability was significantly decreased (P < 0.05); cell apoptosis ratio was increased (P < 0.05); the levels of inflammatory factors, ROS, MDA, and pro-apoptotic proteins were increased (P < 0.05); SOD level, Nrf2, and HO-1 proteins were decreased (P < 0.05). Compared with DOX group, DOX + LCZ696 group significantly inhibited cell damage caused by DOX, while DOX + ML385 group significantly aggravated cell damage. Compared with DOX + LCZ696 group, the cell injury was more severe in DOX + LCZ696 + ML385 group, while the cell injury was reduced in DOX + LCZ696 + ML385 group. Compared with the sham group, the heart tissue damage of mice induced by DOX was serious, the damage caused by DOX was alleviated in DOX + LCZ696 group, and the damage was aggravated in DOX + LCZ696 + ML385 group.Conclusion Sacubitril/Valsartan sodium alleviates DOX-induced myocardial cell injury through Nrf2/HO-1 signaling pathway.